Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
15.97 USD | -1.24% | -0.50% | +9.38% |
Financials (USD)
Sales 2024 * | 14.91M | Sales 2025 * | 82.05M | Capitalization | 1.4B |
---|---|---|---|---|---|
Net income 2024 * | -247M | Net income 2025 * | -202M | EV / Sales 2024 * | 80.4 x |
Net cash position 2024 * | 196M | Net cash position 2025 * | 212M | EV / Sales 2025 * | 14.4 x |
P/E ratio 2024 * |
-5.68
x | P/E ratio 2025 * |
-7.47
x | Employees | 174 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 80.32% |
Latest transcript on Day One Biopharmaceuticals, Inc.
1 day | -1.24% | ||
1 week | -0.50% | ||
Current month | -6.61% | ||
1 month | +6.75% | ||
3 months | +7.25% | ||
6 months | +31.77% | ||
Current year | +9.38% |
Managers | Title | Age | Since |
---|---|---|---|
Samuel Blackman
FOU | Founder | 55 | 18-10-31 |
Jeremy Bender
CEO | Chief Executive Officer | 52 | 20-08-31 |
Charles York
DFI | Director of Finance/CFO | 47 | 21-01-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
J. Garland
BRD | Director/Board Member | 55 | 21-08-16 |
Natalie Holles
BRD | Director/Board Member | 51 | 21-01-31 |
John Josey
BRD | Director/Board Member | 63 | 20-08-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.08% | 0 M€ | 0.00% | - | |
0.06% | 0 M€ | 0.00% | - | |
0.04% | 1,487 M€ | +9.49% | - | |
0.01% | 9 M€ | +11.21% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-20 | 15.97 | -1.24% | 469,882 |
24-05-17 | 16.17 | +0.87% | 421,575 |
24-05-16 | 16.03 | -2.38% | 491,717 |
24-05-15 | 16.42 | -1.20% | 571,842 |
24-05-14 | 16.62 | +3.55% | 331,987 |
Delayed Quote Nasdaq, May 20, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+9.38% | 1.4B | |
+41.79% | 54.04B | |
-0.56% | 41.92B | |
+47.75% | 41.96B | |
-7.20% | 28.35B | |
+12.59% | 26.35B | |
-21.51% | 19B | |
+6.92% | 13B | |
+24.91% | 12.19B | |
+29.60% | 12.28B |
- Stock Market
- Equities
- DAWN Stock